• Latest Posts

How Servier saved Cellectis, the French CAR-T Miracle

Video: Discover How CAR-T Therapies are Working

Pfizer to Control Cellectis in a €1.5 Billion Deal?

With €200 Million, Cellectis is on its way to make the Biggest French Biotech IPO ever

Cellectis is preparing its IPO in the U.S

Review: The CRISPR’s Therapeutical revolution